The Academy scored major kudos during the annual conference of the Alliance for Continuing Education in the Health Professions (ACEhp) in late January, when the AAFP's Amy Mullins, M.D., and Gary Bird, Ph.D., accepted the Alliance's 2017 Innovative Format Award honoring the Academy's PerformanceNavigator CME product.
This is the first year the Alliance has presented the award, which is intended "to recognize outstanding innovation in the delivery format for a certified or non-certified education activity."
Bird, a CME senior learning strategist, told AAFP News that achieving this distinction in the innovation category is particularly rewarding because it recognizes the development of a novel mode of education delivery that resulted in improved learner outcomes.
"Winning this award will help solidify the AAFP as a national leader in medical education," he said.
Mullins, the Academy's medical director of quality improvement, said the AAFP submitted its application for the award in May 2016 and was notified of the win last November.
An article about PerformanceNavigator and its outcomes will be published in April in the ACEhp's monthly newsletter, Almanac.
"This means a large proportion of the medical education providers and professionals in North America will shortly see the Academy's achievement," Mullins said.
About PerformanceNavigatorAccording to Bird, PerformanceNavigator combines various elements, such as American Board of Family Medicine (ABFM)-approved Family Medicine Certification Knowledge Self-Assessment and Performance Improvement activities (previously known as Maintenance of Certification for Family Physicians [MC-FP] Self-Assessment Modules [part II] and Performance-in-Practice Modules [part IV]) and CME credit, with education that enhances clinical skill and promotes practice transformation to improve patient care.
National in scope, PerformanceNavigator was developed to improve family physician learner performance, quality of care, and patient outcomes for one or more of the following chronic cardiometabolic conditions: diabetes, hypertension or dyslipidemia.